Preliminary Program subject to change
Biomarkers: Quantification, PK/PD Correlation and Bioanalytical Issues
Presentation Type	Oral
Summary Statement
Presider:	Michael Hayes, Novartis Pharmaceuticals, East Hanover, NJ
Welcoming Remarks Navigating the Shoals of Biomarker Assays Brian Swanson, Sanofi Avantis Pharmaceuticals, Bridgewater, NJ Discovery, Identification and Quantitation of Biomarkers using iTRAQ™ Reagent Technology Lynn Zieski, Applied Biosystems Corporation, Foster City, CA Development and validation of analytical methods to measure biomarkers in drug development Francois Legay, Novartis Pharma AG, Basel, Switzerland Probing Aging in Zucker Rats Using Ultra Performance Liquid Chromatography Coupled to Time of Flight Mass Spectrometry John Shocklor, Waters Corporation, Milford, MA

General Submissions